Health
Researchers identify how promising therapy may work to improve adverse effects of NAFLD – News-Medical.Net
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
Reviewed by Emily Henderson, B.Sc.Aug 26 2020
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. There are currently no approved medications for NAFLD, but in a study published in the journal JCI Insight on August 20, 2020, investigators conducted a genetic analysis that has identified how one promising t…
-
Noosa News24 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business10 hours agoFord CEO makes stunning prediction about artificial intelligence